A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia.
| Image |  |
|---|---|
| Description | scientific article published on 26 March 2018 |
| Author/s |
author: Sarah R. Cooley |
| Publication date | March 26, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |